UK-based Creo Medical Group PLC is a healthcare research and development company specializing in the creation and distribution of medical instruments and devices. The company's latest innovation, Croma, is an energy platform combining bipolar radiofrequency with microwave energy to provide precise cutting and controlled coagulation. The flexible, endoscope-delivered devices ensure physicians have the flexibility, accuracy, and control they need to perform successful procedures. Other products by Creo include Speedboat Inject, MicroBlate Fine, SlypSeal Flex, SpydrBlade Flex, and endotherapy accessories. Founded in 2003, the company is headquartered in Chepstow, UK.
Creo Medical's ticker is CREO.L
The company's shares trade on the LSE stock exchange
They are based in Chepstow, Wales
There are 201-500 employees working at Creo Medical
It is https://creomedical.com/
Creo Medical is in the Healthcare sector